From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...

In the last 30 years, HIV rates have gone down, in large part because of the game-changing prescription drug pre-exposure ...

Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Still, you might need a secondary form of protection if you ... Centers for Disease Control and Prevention. About HIV. HIV.gov. The stages of HIV infection. HIV.gov. HIV and AIDS: The basics.

This year clinical trial results for PURPOSE 1 and 2 showed the high prevention effectiveness of the 6-monthly long-acting injectable drug, lenacapavir for cisgender adolescent girls and women, ...

Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...

Data reinforce that twice-yearly lenacapavir could be a highly effective and potentially game-changing HIV prevention option. The double-blind, multicenter, randomized study phase III study ...

Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...

Across the entire Cape Metro area, mobile units provide comprehensive HIV testing, treatment and prevention services, including self-­screening, PrEP, antiretroviral drug initiation and follow-up ...

An HIV prevention injection that provides six months of protection per shot has been shown to be highly effective in pivotal studies. The studies found that the jab is safe and highly effective at ...

The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...